A letter from 11 Democrats expresses support for a drug patent provision in the NAFTA update that most of their caucus opposes.
prescription drugs
Posted inHealth and Social Policy
Pramila Jayapal Takes On Medicare for All’s Critics
The Progressive Caucus co-chair authored the House Medicare for All bill. She’s frustrated that Democrats are attacking the concept of universal health care for political advantage.
Posted inEconomic Policy
FTC About to Let Through a ‘Killer Acquisition’
In this Capitol Forum report, the merger of Roche and Spark Therapeutics, which could squash a cure for hemophilia while allowing Roche’s medication for it to thrive, is poised to be approved.
Posted inTAP
Settling for Settlements in the Opioid Crisis
Today on TAP: The weekly roundup, and more fines for misconduct that won’t deter future misconduct
Posted inHealth and Social Policy
How the Drug Industry Sacrifices Children With Cancer
The outrageous, contrived shortage of one of the most widely used generic cancer drugs, vincristine, reflects multiple policy failures.
Posted inHealth and Social Policy
This Pharma-Backed Astroturf Group Wants to Keep Your Drug Prices High
The Coalition Against Socialized Medicine, a project of the American Conservative Union, is advertising on Politico Playbook this week.
Posted inDay One Agenda
Force Drug Companies to Lower Prices
Presidents have two powerful sticks that could weaken the pharmaceutical industry’s power to rake in astronomical profits.
Posted inAmerica and the World
Trump Poised to Give Big Pharma a Big Present in India Trade Deal
Trump and Indian Prime Minister Narendra Modi are discussing an agreement that would lock the world’s second-most-populous country into exclusive prescription drug arrangements.
Posted inTAP
The Oxymoron of House Democratic Governance
It was not a memorable week in the annals of Democratic policymaking. Earlier this week, I wrote a preview of H.R. 3, Nancy Pelosi’s drug-pricing bill, seen as the signature effort of this year’s legislative session. I mentioned in there that the summary, still riddled with questions, probably represented the high-water mark for the bill, […]
Posted inHealth and Social Policy
A Closer Look at Nancy Pelosi’s Plan for Lower Drug Prices
The bill, H.R. 3, has gotten considerably stronger from its initial concept, but questions remain.